Response to pneumococcal vaccination in multiple myeloma
ConclusionMyeloma has the ability to demonstrate a response to pneumococcal vaccine, independently of preexisting hypogammaglobulinemia and possibly of treatment ‐induced immunodepression. We also observed a drop in the serum response overtime and following autologous transplantation. Further studies in larger sample are needed to understand the benefit of vaccination strategies in these patients.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Lo ïc Renaud,
Susanna Schraen,
Guillemette Fouquet,
Stephanie Guidez,
Hélène Demarquette,
Morgane Nudel,
Emilie Cayssials,
Claire Bories,
Charles Herbaux,
Thomas Systchenko,
Jean‐Luc Faucompré,
Antoine Machet,
Florence Sabirou,
Antony L Tags: ORIGINAL RESEARCH Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Men | Meningitis Vaccine | Myeloma | Pneomococcal Vaccine | Stem Cell Therapy | Stem Cells | Study | Transplants | Vaccines